跳至主要内容
临床试验/NCT01756313
NCT01756313已完成4 期

Optimizing Uptake of Methylaminolevulinat With Fractional Ablative Laser Technique

Bispebjerg Hospital2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2012年5月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
12
试验地点
2
主要终点
Fluorescence Intensity

研究概览

简要总结

The objectives of this study is to investigate if pre-treating the skin with an ablative fractional laser that creates small micropores in the skin:

  1. Increases the uptake of Methylaminolevulinat (MAL) in the skin.
  2. Decreases the required incubation time of MAL when performing photo dynamic therapy.

详细描述

12 healthy male individuals were included.

On the back, 25 areas measuring 2.8x2.8 cm were marked, plus one control area. We tested 2 variables.

  1. Density of laser channels. 2) Methylaminolevulinat (MAL) concentration
  1. Laser - Each area was randomized to receiving:
  • no treatment
  • 1% laser channel density
  • 2% laser channel density
  • 5% laser channel density
  • 10% laser channel density
  • 15% laser channel density
  1. MAL - Each density was assigned to 4 areas. Within each density category, the four areas were randomized to receive:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • >18 years old
  • Fitzpatrick skin type I-III
  • No UV exposure thee months prior to study
  • Signed study consent

排除标准

  • Known allergy to substances in MAL or Unguentum M cream.
  • Previous keloid
  • Use of topical or systemic photosensitizing drug
  • Evaluated to not be able to follow treatment protocol

结局指标

主要结局

Fluorescence Intensity

时间窗: up to 3 hours

Fluorescence Intensity measured with a fluorescence camera.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Christina Haak

MD

Bispebjerg Hospital

研究点 (2)

Loading locations...

相似试验

Optimizing Uptake of Methylaminolevulinat With... | 临床试验